くすりのしおり

Injection
Published: 2/2019

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
VIMPAT for I.V. infusion 200mg
 Active ingredient:
Lacosamide
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine calms excessive nerve excitement in the brain and suppresses epileptic seizures.
It is usually used to treat partial seizures when it is impossible to take oral formulation temporarily.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have liver disorder.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • Switching from oral formulation:
    In general, this medicine should be equivalent to the frequency of the oral administration, infused intravenously over a period of 30 minutes to 60 minutes per dose.
  • Before using oral formulation:
    For adults: In general, this medicine is infused intravenously over a period of 30 minutes to 60 minutes per dose twice a day.
    For children: In general, for children from 4 years of age, this medicine is infused intravenously over a period of 30 minutes to 60 minutes per dose twice a day.
  • Once oral administration becomes feasible, this medicine should be immediately replaced with oral formulation.

Precautions while taking this medicine

  • This medicine may cause dizziness, foggy vision, sleepiness, and decrease in attention/concentration/reflex action. Do not perform dangerous operations such as driving a car.
  • If you are a patient with cardiac disorder or taking bradycrotic medicine, electrocardiogram examination may be performed during using this medicine. Keep all laboratory test schedules.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include dizziness, fatigue, somnolence, headache, vomiting, nausea, tremor, double vision, foggy vision and injection site erythema. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • abnormal pulse, shortness of breath, loss of consciousness [atrioventricular block, bradycardia, syncope]
  • fever, erythema, blister/erosion [toxic epidermal necrolysis, mucocutaneous-ocular syndrome]
  • rash, fever, enlarged lymph nodes [drug-induced hypersensitivity syndrome]
  • sore throat, headache, muscle pain [agranulocytosis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z